165 related articles for article (PubMed ID: 36652464)
41. Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect
Davison G
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612951
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of AP-Bio®(KalmCold®) in participants with uncomplicated upper respiratory tract viral infection (common cold) - A phase III, double-blind, parallel group, randomized placebo-controlled trial.
Raj JP; Maurya MR; Nair N; Marfatia H; Hadaye R; Gogtay NJ
Complement Ther Med; 2023 May; 73():102934. PubMed ID: 36842634
[TBL] [Abstract][Full Text] [Related]
43. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.
Mossad SB; Macknin ML; Medendorp SV; Mason P
Ann Intern Med; 1996 Jul; 125(2):81-8. PubMed ID: 8678384
[TBL] [Abstract][Full Text] [Related]
44. The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid.
Barrett B; Brown R; Mundt M; Safdar N; Dye L; Maberry R; Alt J
J Clin Epidemiol; 2005 Jun; 58(6):609-17. PubMed ID: 15878475
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
46. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
[TBL] [Abstract][Full Text] [Related]
47. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial.
Macknin ML; Piedmonte M; Calendine C; Janosky J; Wald E
JAMA; 1998 Jun; 279(24):1962-7. PubMed ID: 9643859
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
49. Reliability and validity of Wisconsin Upper Respiratory Symptom Survey, Korean version.
Yang SY; Kang W; Yeo Y; Park YC
J Epidemiol; 2011; 21(5):313-8. PubMed ID: 21691034
[TBL] [Abstract][Full Text] [Related]
50. Relations among questionnaire and laboratory measures of rhinovirus infection.
Barrett B; Brown R; Voland R; Maberry R; Turner R
Eur Respir J; 2006 Aug; 28(2):358-63. PubMed ID: 16641127
[TBL] [Abstract][Full Text] [Related]
51. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults.
Mossad SB
QJM; 2003 Jan; 96(1):35-43. PubMed ID: 12509647
[TBL] [Abstract][Full Text] [Related]
52. Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).
Pshenichnaya NY; Bulgakova VA; Lvov NI; Poromov AA; Selkova EP; Grekova AI; Shestakova IV; Maleev VV; Leneva IA
Ter Arkh; 2019 Mar; 91(3):56-63. PubMed ID: 31094461
[TBL] [Abstract][Full Text] [Related]
53. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
54. The effect of inhaled and intranasal sodium cromoglycate on symptoms of upper respiratory tract infections.
Aberg N; Aberg B; Alestig K
Clin Exp Allergy; 1996 Sep; 26(9):1045-50. PubMed ID: 8889259
[TBL] [Abstract][Full Text] [Related]
55. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms.
Gaffey MJ; Kaiser DL; Hayden FG
Pediatr Infect Dis J; 1988 Mar; 7(3):223-8. PubMed ID: 2895909
[TBL] [Abstract][Full Text] [Related]
56. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge.
Doyle WJ; McBride TP; Skoner DP; Maddern BR; Gwaltney JM; Uhrin M
Pediatr Infect Dis J; 1988 Mar; 7(3):229-38. PubMed ID: 3282216
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial.
Wang S; Jiang H; Yu Q; She B; Mao B
Trials; 2017 Jan; 18(1):2. PubMed ID: 28057058
[TBL] [Abstract][Full Text] [Related]
58. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
59. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial.
Barrett BP; Brown RL; Locken K; Maberry R; Bobula JA; D'Alessio D
Ann Intern Med; 2002 Dec; 137(12):939-46. PubMed ID: 12484708
[TBL] [Abstract][Full Text] [Related]
60. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
Weisler RH; Pandina GJ; Daly EJ; Cooper K; Gassmann-Mayer C;
CNS Drugs; 2012 May; 26(5):421-34. PubMed ID: 22519922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
